American Association for Cancer Research

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications

Bookmark and Share


Advances in Breast Cancer Research 2011. Multicolor immunofluorescence image of normal human breast tissue to detect the expression of CD44 (red), CD24 (yellow), and p27 (green). Nuclei were counterstained with DAPI (blue). Image was acquired using a Nikon Ti microscope attached to a Yokogawa spinning-disk confocal unit, 60x plan apo objective, and OrcaER camera controlled by Andor iQ software. Photo taken and experiment performed by Dr. Vanessa Almendro, postdoctoral fellow, Dana-Farber Cancer Institute.Advances in Breast Cancer Research:
Genetics, Biology, and Clinical Applications
October 12-15, 2011
The Fairmont San Francisco
San Francisco, CA

José Baselga, Massachusetts General Hospital, Boston, MA
Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA
Jeffrey M. Rosen, Baylor College of Medicine, Houston, TX

This was the sixth AACR Special Conference on Advances in Breast Cancer Research, the first in the series to be designated as a Continuing Medical Education Activity. The 2011 program featured thought leaders from around the world who presented their latest research in the areas of endocrine resistance, epigenomics/genomics, inflammation, metabolomics, noncoding RNAs, stem cells, and targeted therapies. Dr. Joan S. Brugge of the Harvard Medical School and Dr. Neal Rosen of the Memorial Sloan-Kettering Cancer Center presented keynote talks, and a special panel discussion on Transforming Translational Research was presented by The Love/Avon Army of Women. Poster sessions allowed over 200 investigators to present and discuss their latest research in an informal setting with over 400 researchers from 30 different countries - providing ample networking and collaboration-building opportunities.

Lead Supporter
Susan G. Komen for the Cure(R)

* Adobe Acrobat Reader required

Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.